Active ingredientMozavaptanCat. No. P-M178-001CAS 137975-06-5Family · Pharmaceutical analytical standards
Mozavaptan
A vasopressin receptor antagonist (vaptan) with a benzazepine structure, approved in Japan in October 2006 for hyponatraemia due to inappropriate antidiuretic hormone secretion (SIADH) caused by ADH-producing tumours. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is an aquaretic: unlike classic diuretics it increases the water passed in urine without loss of sodium and chloride. During development it was known by the code OPC-31260.
Go to the active ingredient →Active ingredientMozavaptanCat. No. P-M178-001CAS 137975-06-5
Isotopically labelledMozavaptan-d6Cat. No. P-M178-002CAS 2750534-83-7
ImpurityMozavaptan Impurity 1Cat. No. P-M178-003CAS 137976-61-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.